Altos Labs has officially announced a groundbreaking funding achievement, successfully raising a monumental $3 billion to propel its pioneering efforts in the realm of biotechnology. With a vision centered around restoring cell health and resilience, Altos Labs is at the forefront of cell rejuvenation technology, aiming to reverse the debilitating effects of disease, injury, and the natural decline associated with aging. This significant funding underscores the overwhelming confidence investors have in Altos Labs’ mission and the expertise of its pioneering community. Comprising some of the brightest minds in science, clinical research, and industry, the company boasts a collaborative spirit that drives innovative solutions aimed at enhancing longevity and overall health. Operating out of key hubs in the San Francisco Bay Area, San Diego, and Cambridge, UK, Altos is strategically positioned to leverage a rich network of resources and talent in leading-edge research and development. The newly acquired funds will primarily focus on expanding their advanced research initiatives, enhancing their technology infrastructure, and nurturing collaborations that emphasize transformative treatments for age-related diseases and conditions. In a world increasingly affected by chronic health issues, Altos Labs is committed to redefining the future of healthcare and empowering individuals to regain control over their health span. As they embark on this exciting chapter, the company reaffirms its dedication to ethical practices, ensuring that all potential employees and partners are treated with respect and transparency. This new chapter is an ambitious step toward realizing a healthier future for everyone.
Altos Labs Secures $3 Billion in Funding to Revolutionize Cell Rejuvenation and Disease Reversal
Recently funded · $3.0BBiotechnology
Get the full Altos Labs company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
